The Cochrane Collaboration at 10: kudos and challenges

September 2004
CMAJ: Canadian Medical Association Journal;9/28/2004, Vol. 171 Issue 7, p701
Academic Journal
Introduces a series of articles related to the Cochrane Collaboration which compiled all randomized clinical trials in the perinatal field of medicine. Outcome of the collaboration in its first 10 years; Problem with the manipulation of research objectives to yield better results.


Related Articles

  • How Do Institutional Review Boards Apply the Federal Risk and Benefit Standards for Pediatric Research? Shah, Seema; Whittle, Amy; Wilfond, Benjamin; Gensler, Gary; Wendler, David // JAMA: Journal of the American Medical Association;1/28/2004, Vol. 291 Issue 4, p476 

    Context: Federal regulations allow children in the United States to be enrolled in clinical research only when the institutional review board (IRB) determines that the risks are minimal or a minor increase over minimal, or that the research offers a prospect of direct benefit. Despite this...

  • Clinical Trials in New Europe. DOIG, AL // Bio-IT World;Jan2009, Vol. 8 Issue 1, p13 

    The article presents an outlook for clinical trials in New Europe for 2009. The collapse of the Soviet Union is cited as one of the major factors which contributed to the emergence of new opportunity for clinical trials in Europe. An overview of the report from Insight Pharma Reports entitled...

  • Relevance of the clinical impact factor. Blitzkow, Gilson; Estrela, Carlos // Dental Press Endodontics;Jan-Apr2015, Vol. 5 Issue 1, p5 

    The author discusses the importance of systematic literature reviews to analyze clinical impact factors and select accurate and appropriate articles.

  • Research In Tropical Pediatrics. Brown, Roy E. // Clinical Pediatrics;Mar1966, Vol. 5 Issue 3, p197 

    Discusses key issues concerning pediatric research in tropical regions. Clinical trials; Local disease patterns; General research principles.

  • The clinical trial imperative. Gipson, Debbie; Trachtman, Howard // Pediatric Nephrology;Jan2005, Vol. 20 Issue 1, p5 

    As clinical judgment has joined forces with evidence-based medicine, nephrologists critically assess the validity of the data available to support therapeutic decisions for children with kidney disease. Unfortunately, a paucity of data often prevents the practice of evidence-based medicine....

  • Clinical trials: the viewpoint of children. Cherrill, J.; Hudson, H.; Cocking, C.; Unsworth, V.; Franck, L.; McIntyre, J.; Choonara, I. // Archives of Disease in Childhood;Aug2007, Vol. 92 Issue 8, p712 

    The views of 30 children (8-16 years old) attending paediatric medical clinics on paediatric clinical trials were determined by semi-structured interviews. Nineteen children recognised that there were risks involved with taking part in clinical trials. Risks concerned with being paid were...

  • The Continuum of Comparability Extends to Biosimilarity: How Much Is Enough and What Clinical Data Are Necessary? McCamish, M; Woollett, G // Clinical Pharmacology & Therapeutics;Apr2013, Vol. 93 Issue 4, p315 

    The article offers information on the comparability and biosimilarity of regulatory and scientific concepts of clinical data in the U.S. It mentions the standards needed to get approval for biologics and biosimilar manufacturing changes. Moreover, it features the needed investments to...

  • Improve your research contract, negotiation skills.  // Clinical Trials Administrator;Mar2010, Vol. 8 Issue 3, p34 

    The article offers helpful information on improving research contracts by understanding the motivations of the parties involved. It advises clinical administrators and investigators to know what benefits can be gained such as the publication rights of the study while the sponsors have different...

  • Lessons Learned from Large Cardiovascular Trials. Rumboldt, Zvonko // Medicinski Arhiv;2007 Supplement, Vol. 61 Issue 2, p38 

    Controlled clinical trial methodology includes unbiased data gathering, subject to statistical analysis, eliminating subjective and environmental influences on the results. These studies compare treatments in patients minimizing or equalizing all variables except the intervention (mostly a drug)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics